Antibodies as pharmacologic tools for studies on the regulation of energy balance

Nutrition

Volumn 24, Issue 9, 2008, Pages 791-797

  Hofbauer, Karl G ^a   Lecourt, Anne Catherine ^a   Peter, Jean Christophe ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Anorexia; Food intake; G protein coupled receptor; Immunization; Inverse agonist; Lipopolysaccharide; Melanocortin 4 receptor

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CYCLIC AMP; CYSTEINYLALANYLASPARAGINYLISOLEUCYLSERYLARGINYLGLUTAMYL GLUTAMYLARGINYLARGINYLGLUTAMYLVALYLPHENYLALANYLLEUCYLSERYLVALYLPROLYL GLYCYLLEUCINE; CYSTEINYLALANYLASPARAGINYLISOLEUCYLSERYLARGINYLGLUTAMYL GLUTAMYLARGINYLARGINYLGLUTAMYLVALYLPHENYLALANYLLEUCYLSERYLVALYLPROLYL GLYCYLLEUCINE ANTIBODY; CYTOKINE; INSULIN; LIPOPOLYSACCHARIDE; LYSYLTHREONYLSERYLLEUCYLHISTIDYLLEUCYLTRYPTOPHYLASPARAGINYLARGINYL SERYLSERYLHISTIDYLGLYCYLLEUCYLHISTIDYLGLYCINAMIDE; LYSYLTHREONYLSERYLLEUCYLHISTIDYLLEUCYLTRYPTOPHYLASPARAGINYLARGINYL SERYLSERYLHISTIDYLGLYCYLLEUCYLHISTIDYLGLYCINAMIDE ANTIBODY; MELANOCORTIN 4 RECEPTOR; PEPTIDE ANTIBODY; PEPTIDE DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BODY WEIGHT; CACHEXIA; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENERGY BALANCE; ENZYME SYNTHESIS; FATTY LIVER; FEMALE; FOOD INTAKE; HUMAN; HUMAN CELL; HYPOTHALAMUS; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID DIET; LIVER WEIGHT; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RAT; RECEPTOR BLOCKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADENOSINE MONOPHOSPHATE; ADIPOSE TISSUE; ANIMALS; ANOREXIA; ANTIBODIES; BODY WEIGHT; DIET; DIETARY FATS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FATTY LIVER; FEEDING BEHAVIOR; HUMANS; INSULIN; LIPOPOLYSACCHARIDES; LIVER; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 4; SODIUM CHLORIDE; TRIGLYCERIDES;

RATTUS;

EID: 49749107656     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.06.001     Document Type: Article

References (29)

1. Adan R.A., Tiesjema B., Hillebrand J.J., la Fleur S.E., Kas M.J., and de Krom M. The MC4 receptor and control of appetite. Br J Pharmacol 149 (2006) 815-827
2. Cowley M.A. Hypothalamic melanocortin neurons integrate signals of energy state. Eur J Pharmacol 480 (2003) 3-11
3. Ellacott K.L., and Cone R.D. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog Horm Res 59 (2004) 395-408
4. Farooqi I.S., Keogh J.M., Yeo G.S., Lank E.J., Cheetham T., and O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348 (2003) 1085-1095
5. Deboer M.D., and Marks D.L. Cachexia: lessons from melanocortin antagonism. Trends Endocrinol Metab 17 (2006) 199-204
6. Marks D.L., Ling N., and Cone R.D. Role of the central melanocortin system in cachexia. Cancer Res 61 (2001) 1432-1438
7. Peter J.C., Nicholson J.R., Heydet D., Lecourt A.C., Hoebeke J., and Hofbauer K.G. Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 292 (2007) R2151-R2158
8. Nicholson J.R., Peter J.C., Lecourt A.C., Barde Y.A., and Hofbauer K.G. Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J Neuroendocrinol 19 (2007) 974-982
9. Peter J.C., Zipfel G., Lecourt A.C., and Hofbauer K.G. Active immunization against the melanocortin-3 and -4 receptor results in different phenotypes in rats (abstract). Int J Obes Relat Metab Disord (2008) (in press)
10. Neimark J., and Briand J.P. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept Res 6 (1993) 219-228
11. Sebhat I.K., Martin W.J., Ye Z., Barakat K., Mosley R.T., Johnston D.B., et al. Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium-3-ylcarbonyl]-(1R)-1-(4-chlorob enzyl)-2-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)piperidin-1-yl]-2- oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem 45 (2002) 4589-4593
12. Nordheim U., Nicholson J.R., Dokladny K., Dunant P., and Hofbauer K.G. Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive rats. Peptides 27 (2006) 438-443
13. Chen M., Celik A., Georgeson K.E., Harmon C.M., and Yang Y. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism. Regul Pept 136 (2006) 40-49
14. Srinivasan S., Lubrano-Berthelier C., Govaerts C., Picard F., Santiago P., Conklin B.R., et al. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 114 (2004) 1158-1164
15. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268 (1993) 15174-15179
16. Mirzadegan T., Benko G., Filipek S., and Palczewski K. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42 (2003) 2759-2767
17. Kamel R., Eftekhari P., Garcia S., Berthouze M., Berque-Bestel I., Peter J.C., et al. A high-affinity monoclonal antibody with functional activity against the 5-hydroxytryptaminergic (5-HT(4)) receptor. Biochem Pharmacol 70 (2005) 1009-1018
18. Peter J.C., Tugler J., Eftekhari P., Maurice D., Hoebeke J., and Roegel J.C. Effects on heart rate of an anti-M2 acetylcholine receptor immune response in mice. FASEB J 19 (2005) 943-949
19. Banks W.A., Terrell B., Farr S.A., Robinson S.M., Nonaka N., and Morley J.E. Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease. Peptides 23 (2002) 2223-2226
20. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 8 (2005) 571-578
21. Fan W., Dinulescu D.M., Butler A.A., Zhou J., Marks D.L., and Cone R.D. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141 (2000) 3072-3079
22. Obici S., Feng Z., Tan J., Liu L., Karkanias G., and Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Invest 108 (2001) 1079-1085
23. Small C.J., Kim M.S., Stanley S.A., Mitchell J.R., Murphy K., Morgan D.G., et al. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 50 (2001) 248-254
24. Matsushita A., Iwase M., Kato Y., Ichihara S., Ichihara G., Kimata H., et al. Differential cardiovascular effects of endotoxin derived from Escherichia coli or Pseudomonas aeruginosa. Exp Anim 56 (2007) 339-348
25. Felies M., von Horsten S., Pabst R., and Nave H. Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats. J Physiol 561 pt 1 (2004) 245-252
26. Huang Q.H., Hruby V.J., and Tatro J.B. Role of central melanocortins in endotoxin-induced anorexia. Am J Physiol Regul Integr Comp Physiol 276 pt 2 (1999) R864-R871
27. Brekke O.H., and Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2 (2003) 52-62
28. Hudson P.J., and Souriau C. Engineered antibodies. Nat Med 9 (2003) 129-134
29. Reichert J.M. Monoclonal antibodies in the clinic. Nat Biotechnol 19 (2001) 819-822